AIDCyclin AKO cells from HeLa were generated by retroviral infection (25 (link)) using the construct AID-cyclin A in pRevTRE-AID/Hyg, followed by transfection of cyclin A CRISPR-Cas9 in pX330. AIDCyclin AKO cells from H1299 were generated by transfecting H1299 cells with AID-cyclin A in pUHD-SB-AID/Hyg, pSBbi-TIR1-tTA/Pur (26 (link)), cyclin A CRISPR-Cas9 in pX330, and Sleeping Beauty transposase (pCMV(CAT)T7-SB100; a gift from Zsuzsanna Izsvak; Addgene, #34879) before selecting with hygromycin and puromycin for 2 weeks. AIDCyclin AKO cells lacking CDK2 were generated by cotransfecting CDK2 CRISPR-Cas9 in pX330 and a plasmid expressing blasticidin-resistant gene (a gift from Tim Hunt, Cancer Research UK) into AIDCyclin AKO HeLa cells. After enriching the transfected cells with blasticidin selection for 36 h, the cells were recovered in blasticidin-free medium for 48 h. In all the above cell lines, single cell-derived colonies were obtained by limiting dilution in 96-well plates.
Generation of cell lines with AID-tagged proteins
AIDCyclin AKO cells from HeLa were generated by retroviral infection (25 (link)) using the construct AID-cyclin A in pRevTRE-AID/Hyg, followed by transfection of cyclin A CRISPR-Cas9 in pX330. AIDCyclin AKO cells from H1299 were generated by transfecting H1299 cells with AID-cyclin A in pUHD-SB-AID/Hyg, pSBbi-TIR1-tTA/Pur (26 (link)), cyclin A CRISPR-Cas9 in pX330, and Sleeping Beauty transposase (pCMV(CAT)T7-SB100; a gift from Zsuzsanna Izsvak; Addgene, #34879) before selecting with hygromycin and puromycin for 2 weeks. AIDCyclin AKO cells lacking CDK2 were generated by cotransfecting CDK2 CRISPR-Cas9 in pX330 and a plasmid expressing blasticidin-resistant gene (a gift from Tim Hunt, Cancer Research UK) into AIDCyclin AKO HeLa cells. After enriching the transfected cells with blasticidin selection for 36 h, the cells were recovered in blasticidin-free medium for 48 h. In all the above cell lines, single cell-derived colonies were obtained by limiting dilution in 96-well plates.
Corresponding Organization : University of Hong Kong
Variable analysis
- HeLa (cervical carcinoma) cell line expressing the tTA tetracycline transactivator
- H1299 cell line
- AIDcdk1KO cell line
- AIDcdk2KO cell line
- MAIDCyclin B1KO HeLa cell line
- AIDCyclin AKO HeLa cell line
- AIDCyclin AKO H1299 cell line
- AIDCyclin AKO HeLa cells lacking CDK2
- Not explicitly mentioned
- Not explicitly mentioned
- Positive control: Not mentioned
- Negative control: Not mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!